These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 6818852

  • 1. Essential fatty acid deficient rats: a new model for evaluating arachidonate metabolism in shock.
    Cook JA, Wise WC, Knapp DR, Halushka PV.
    Adv Shock Res; 1981; 6():93-105. PubMed ID: 6818852
    [Abstract] [Full Text] [Related]

  • 2. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
    Cook JA, Wise WC, Halushka PV.
    J Clin Invest; 1980 Jan; 65(1):227-30. PubMed ID: 7350199
    [Abstract] [Full Text] [Related]

  • 3. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
    Wise WC, Cook JA, Halushka PV.
    Adv Shock Res; 1981 Jan; 6():83-91. PubMed ID: 6961767
    [Abstract] [Full Text] [Related]

  • 4. Resistance of essential fatty acid-deficient rats to endotoxin-induced increases in vascular permeability.
    Li EJ, Cook JA, Spicer KM, Wise WC, Rokach J, Halushka PV.
    Circ Shock; 1990 Jun; 31(2):159-70. PubMed ID: 2188748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thromboxane and prostacyclin production during septic shock.
    Butler RR, Wise WC, Halushka PV, Cook JA.
    Adv Shock Res; 1982 Jun; 7():133-45. PubMed ID: 6753528
    [Abstract] [Full Text] [Related]

  • 9. Resistance of essential fatty acid-deficient rats to endotoxic shock.
    Cook JA, Wise WC, Callihan CS.
    Circ Shock; 1979 Jun; 6(4):333-42. PubMed ID: 394879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gentamicin and indomethacin in the treatment of septic shock: effects on prostacyclin and thromboxane A2 production.
    Butler RR, Wise WC, Halushka PV, Cook JA.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):94-101. PubMed ID: 6339712
    [Abstract] [Full Text] [Related]

  • 17. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K, Anzeveno P, Cook JA, Halushka PV, McCarthy J, Wagner E, Wise WC.
    Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
    [Abstract] [Full Text] [Related]

  • 18. Essential fatty acid-deficient diet modifies PAF levels in stomach and duodenum of endotoxin-treated rats.
    Autore G, Cicala C, Cirino G, Maiello FM, Mascolo N, Capasso F.
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):145-53. PubMed ID: 8012761
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock.
    Sakanishi N, Tsunoda Y, Takekawa K, Ikezono E.
    Bull Tokyo Med Dent Univ; 1983 Jun; 30(2):37-46. PubMed ID: 6580966
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.